NEW YORK (GenomeWeb) – PreventionGenetics said late Monday that it received a New York State Department of Health license.

The company previously received CLIA accreditation, as well as ISO 15189:2012 accreditation, allowing it to perform clinical genetic testing on human specimens in the US and internationally. New York and a few other states require additional licensure, however. PreventionGenetics will now be able to perform testing on specimens from New York without an additional permit application process, the company's Founder and President James Weber said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.